STOCKHOLM, November 30, 2015 - Karo Bio AB (publ) today an-nounced that the company’s total number of shares as per Novem-ber 30, 2015 amounted to 49 925 755 shares, corresponding to an equal number of votes. The increase in the number of shares and votes results from the recently completed acquisition of more than 90% of the shares in MedCore AB and the directed new share issue of 381 634 shares to the shareholders in MedCore AB. FOR FURTHER INFORMATION PLEASE CONTACT: Henrik Palm, CFO, phone 070-540 40 14 or e-mail henrik.palm@karobio.se ABOUT KARO BIO Karo Bio is a healthcare company that develops and markets products to pharmacies and directly to healthcare providers. The share is listed on Nasdaq Stockholm. The information in this report is such that Karo Bio is required to disclose under the Swedish Securities Market Act. The infor-mation was disclosed on November 30, 2015 at 8.30 a.m. CET. This press release is also available on www.karobio.se and www.newsroom.cision.com .
CHANGE OF THE NUMBER OF SHARES AND VOTES IN KARO BIO
| Source: Karo Pharma AB